SPRB

Spruce Biosciences, Inc. Common Stock
SPRB

Upgrade to unlock
Buy
Hold
Sell

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$185
216% upside
High target

2 analyst ratings

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Citizens
Citizens
Jonathan Wolleben
0% 1-yr SPRB win rate
10 Mar ‘26 20 days ago
HC Wainwright & Co
HC Wainwright & Co
Raghuram Selvaraju
33% 1-yr SPRB win rate
10 Mar ‘26 20 days ago